首页> 外文期刊>Jornal Brasileiro de Psiquiatria >Psychosis associated with methimazole-induced hypothyroidism: a case report
【24h】

Psychosis associated with methimazole-induced hypothyroidism: a case report

机译:甲巯咪唑致甲状腺功能低下的精神病:一例报告

获取原文
           

摘要

INTRODUCTION: Thyroid dysfunction has often been associated with several psychiatric manifestations. Previous case reports/series suggest the possible role played by acute alteration of thyroid status in the onset of psychotic symptoms. METHODS: Case report and literature review. RESULTS: A 45-year-old woman with no psychiatric antecedents was brought to the ER with a full-blown psychotic episode, marked by paranoid delusions, which developed gradually over two months. She had been treated elsewhere for hyperthyroidism for five years with methimazole 40 mg/d, with poor compliance. One month before the beginning of the psychotic symptoms, methimazole was raised to 60 mg/d and she started taking it correctly. Five months earlier she had TSH: 0.074 uUI/ml and free T4: 1.3 ng/dl. At admission we found a diffuse thyroid goiter, TSH: 70.9 uUI/ml and free T4: 0.03 ng/dl. Brain CT was normal. We hospitalized her with the diagnosis of a psychosis secondary to hypothyroidism, suspended methimazole, and gave her levothyroxine (up to 75 μg/d) and risperidone (2 mg/d). The patient had a quick remission and was discharged after 15 days. Within one month she had TSH: 0.7 uUI/ml and was completely recovered psychiatrically. She has been well since then, with risperidone in the first 8 months, and without it for 10 months now. CONCLUSION: This case report is a reminder of the necessity of checking thyroid status as part of clinical assessment of psychoses. It also supports the hypothesis that antithyroid drugs may have severe psychiatric consequences, especially when they lead to an acute change of thyroid status.
机译:简介:甲状腺功能障碍常与多种精神病学表现有关。先前的病例报告/系列提示,甲状腺状态的急性改变可能在精神病性症状发作中发挥作用。方法:病例报告和文献复习。结果:一名没有精神病前因的45岁妇女被带入急诊室,出现了全面的精神病发作,表现为偏执妄想,并在两个月内逐渐发展。她曾在其他地方接受甲亢唑40 mg / d治疗甲亢,但依从性差。精神病症状开始前一个月,甲他唑提高到60 mg / d,她开始正确服用。 5个月前,她的TSH:0.074 uUI / ml,游离T4:1.3 ng / dl。入院时我们发现了甲状腺弥漫性甲状腺肿,TSH:70.9 uUI / ml,游离T4:0.03 ng / dl。脑部CT正常。我们住院诊断患有甲减的继发性精神病,暂停了甲巴唑,并给了她左甲状腺素(最高75μg/ d)和利培酮(2 mg / d)。该患者迅速缓解,在15天后出院。在一个月内,她的TSH:0.7 uUI / ml,并且在精神病学上完全康复。从那时起,她一直处于良好状态,前8个月使用利培酮,而现在10个月没有使用利培酮。结论:本病例报告提醒人们必须检查甲状腺状况,作为对精神病进行临床评估的一部分。它还支持以下假设:抗甲状腺药物可能会产生严重的精神病后果,尤其是当它们导致甲状腺状态的急性改变时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号